A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Abbott Laboratories stock. As of the latest transaction made, Citadel Advisors LLC holds 1,814,900 shares of ABT stock, worth $210 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,814,900
Previous 2,624,700 30.85%
Holding current value
$210 Million
Previous $273 Million 24.13%
% of portfolio
0.04%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $62.3 Million - $73.5 Million
-622,172 Reduced 63.23%
361,753 $41.2 Million
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $67.9 Million - $75.8 Million
674,456 Added 217.94%
983,925 $102 Million
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $14.7 Million - $16.2 Million
134,185 Added 76.55%
309,469 $35.2 Million
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $53.7 Million - $65.7 Million
-595,131 Reduced 77.25%
175,284 $19.3 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $56.4 Million - $67.7 Million
590,255 Added 327.63%
770,415 $74.6 Million
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $106 Million - $119 Million
-1,056,212 Reduced 85.43%
180,160 $19.6 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $79.4 Million - $93.5 Million
819,764 Added 196.77%
1,236,372 $125 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $8.48 Million - $9.95 Million
89,249 Added 27.26%
416,608 $45.7 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $13.1 Million - $15.2 Million
135,782 Added 70.88%
327,359 $31.7 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $64.8 Million - $78.3 Million
-634,822 Reduced 76.82%
191,577 $20.8 Million
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $82.8 Million - $101 Million
725,764 Added 721.18%
826,399 $97.8 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $45.5 Million - $55.7 Million
-393,463 Reduced 79.63%
100,635 $14.2 Million
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $4.05 Million - $4.48 Million
34,709 Added 7.56%
494,098 $58.4 Million
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $39.9 Million - $46.9 Million
376,924 Added 457.07%
459,389 $53.3 Million
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $8.41 Million - $9.91 Million
-77,255 Reduced 48.37%
82,465 $9.88 Million
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $248 Million - $270 Million
-2,358,863 Reduced 93.66%
159,720 $17.5 Million
Q3 2020

Nov 16, 2020

BUY
$91.64 - $111.29 $64.6 Million - $78.4 Million
704,455 Added 38.83%
2,518,583 $274 Million
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $94.2 Million - $121 Million
1,230,393 Added 210.78%
1,814,128 $166 Million
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $20.2 Million - $29.6 Million
321,716 Added 122.78%
583,735 $46.1 Million
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $10.2 Million - $11.4 Million
130,300 Added 98.92%
262,019 $22.8 Million
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $4.55 Million - $4.94 Million
55,613 Added 73.07%
131,719 $11 Million
Q2 2019

Aug 14, 2019

SELL
$72.88 - $85.0 $169 Million - $197 Million
-2,314,178 Reduced 96.82%
76,106 $6.4 Million
Q1 2019

May 15, 2019

BUY
$66.22 - $80.06 $149 Million - $180 Million
2,246,034 Added 1557.04%
2,390,284 $0
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $69.4 Million - $78.6 Million
-1,058,837 Reduced 88.01%
144,250 $10.4 Million
Q3 2018

Nov 13, 2018

BUY
$60.81 - $73.36 $37.1 Million - $44.8 Million
610,559 Added 103.04%
1,203,087 $0
Q2 2018

Aug 10, 2018

SELL
$57.57 - $63.54 $194 Million - $214 Million
-3,368,557 Reduced 85.04%
592,528 $0
Q1 2018

May 11, 2018

SELL
$56.27 - $63.62 $142 Million - $161 Million
-2,528,968 Reduced 38.97%
3,961,085 $237 Million
Q4 2017

Feb 09, 2018

BUY
$53.68 - $57.47 $125 Million - $134 Million
2,329,414 Added 55.99%
6,490,053 $370 Million
Q3 2017

Nov 09, 2017

BUY
$48.06 - $53.64 $200 Million - $223 Million
4,160,639
4,160,639 $222 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.